Clonality assessment in blood of patients with mantle cell lymphoma.
The presence of circulating neoplastic cells at diagnosis was assessed in the blood of patients presenting with mantle cell lymphoma (MCL) to determine the feasibility of a diagnostic molecular assay. Blood samples from 16 patients with pathologically reviewed MCL were analysed for the t(11;14)(q13;q32) translocation by the polymerase chain reaction (PCR): 7 (44%) were found positive. The remaining cases were examined by PCR for the presence of circulating neoplastic B-cells by amplifying the third complementarity region (CDR3) of immunoglobulin heavy chain genes and the immunoglobulin light kappa chain deletion rearrangements. A further 7 (44%) patients showed the presence of clonal lymphoma cells, leaving only 2 (12%) of cases negative for circulating lymphomatous cells. This study suggests that there is a high incidence of lymphoma cells in the blood of patients presenting with MCL. PCR for these clonal cells may be diagnostically useful.
Servizio Oncologico Cantonale, Ospedale San Giovanni, Bellinzona, Switzerland.
F
F
Bertoni
E
E
Roggero
P
P
Luscieti
E
E
Pedrinis
F
F
Cavalli
E
E
Zucca
D002999:Clone Cells / Q000473:pathology; D006801:Humans; D018655:Lymphocyte Count; D008228:Lymphoma, Non-Hodgkin / Q000097:blood* / Q000235:genetics / Q000473:pathology*; D016133:Polymerase Chain Reaction